Upper Limb Rehabilitation Robot segmentation by type distinguishes three principal architectures—exoskeleton, end‑effector, and wearable assistive systems—each contributing uniquely to market size. Exoskeletons, which align joint axes with the user’s anatomy, represent the largest share at roughly 55 %, driven by their ability to deliver multi‑joint assistance and collect comprehensive biomechanical data, making them attractive for both clinical research and high‑volume therapy centers. End‑effector devices, accounting for about 30 % of sales, focus on hand‑ or forearm‑mounted interfaces that generate task‑specific forces; their relative mechanical simplicity lowers capital cost, supporting adoption in smaller outpatient facilities. Wearable assistive robots, a rapidly expanding niche with an estimated 15 % share, integrate lightweight actuators and sensor suites directly into garments, enabling home‑based rehabilitation and continuous monitoring. The distribution across these types reflects a trade‑off between functional breadth, equipment cost, and deployment setting, influencing manufacturers’ product‑roadmaps and investors’ allocation of capital within the Upper Limb Rehabilitation Robot market. Consequently, R&D budgets are skewed toward exoskeleton scalability, while end‑effector and wearable segments attract niche funding for portability and cost reduction.
